|
0
Votes
vote
Test of Experimental Alzheimer's Drug Doesn't Even Support Comparison MedicationA recent study testing the efficacy of AZD3480, an experimental drug for Alzheimer's disease, obtained inconclusive results. This isn't surprising, considering that other experimental Alzheimer's medications have created false hopes before... ... |
|
2
Votes
vote
Cases: In a Place of Dying, Slight Shadows of LifeAlzheimer’s closed in on a wife early, grindingly taking over more than half of our years together. ... |
|
0
Votes
vote
Grand Rapids Press examines Alzheimer's disease care among HispanicsThe Grand Rapids Press on Tuesday examined the "cultural tightrope" faced by some Hispanics who seek long-term care for a family member with Alzheimer's disease. ... |
|
2
Votes
vote
Exercise can help memory, study saysAdding 20 minutes of exercise to a person's daily routine could reduce the risk of developing Alzheimer's, according to a study published in Wednesday's Journal of the American Medical Association. ... |
|
2
Votes
vote
Pfizer gains rights to Medivation Alzheimer's drugNEW YORK (Reuters) - Pfizer Inc is acquiring rights to a promising experimental drug for Alzheimer's disease from Medivation Inc for as much as $725 million, sending Medivation shares up nearly 31 percent. ... |
|
0
Votes
vote
Antipsychotic Drugs Pose More Risks for Alzheimer's IndividualsA few months ago, I expressed concern over the frequent use of antipsychotic medications to manage behavioral symptoms of Alzheimer's disease, given that those taking these kinds of drugs are... ... |

